Atsushi Obata
About
Atsushi Obata is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology.
According to data from OpenAlex, Atsushi Obata has authored 80 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Surgery and 25 papers in Molecular Biology. Recurrent topics in Atsushi Obata's work include Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (29 papers) and Diabetes Management and Research (19 papers). Atsushi Obata is often cited by papers focused on Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (29 papers) and Diabetes Management and Research (19 papers). Atsushi Obata collaborates with scholars based in Japan, United States and Switzerland. Atsushi Obata's co-authors include Hideaki Kaneto, Kohei Kaku, Masashi Shimoda, Tomohiko Kimura, Yasuhisa Fujibayashi, Yoshiharu Yonekura, Tomoatsu Mune, Hideo Saji, Michael J. Welch and Kenji Kohara and has published in prestigious journals such as Diabetes, Scientific Reports and Biochemical and Biophysical Research Communications.
In The Last Decade
Atsushi Obata
72 papers receiving 1.7k citations
Peers
Atsushi Obata
In Joo Kim South Korea
Joanna Kłubo-Gwieździńska United States
Gabriela M. Kuster Switzerland
Tomonori Itoh Japan
Henrik Wiggers Denmark
Keisuke Ohba Japan
Nadia Haddy France
John J. Ryan United States
Charles Intenzo United States
Sunghwan Suh South Korea
Citations per year, relative to Atsushi Obata Atsushi Obata (= 1×)
peers
In Joo Kim
Countries citing papers authored by Atsushi Obata
Since
Specialization
Citations
This map shows the geographic impact of Atsushi Obata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Obata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Obata more than expected).
Fields of papers citing papers by Atsushi Obata
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Atsushi Obata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Obata. The network helps show where Atsushi Obata may publish in the future.
Co-authorship network of co-authors of Atsushi Obata
This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Obata. A scholar is included among the top collaborators of Atsushi Obata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Obata. Atsushi Obata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shimoda, Masashi, Masahiro Iwamoto, Shuhei Nakanishi, et al.. (2024). Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study). Frontiers in Endocrinology. 15. 1412553–1412553.
2.
Sanada, Junpei, Atsushi Obata, Yoshiro Fushimi, et al.. (2022). Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules. Scientific Reports. 12(1). 13220–13220.
3.
Fushimi, Yoshiro, Shinji Kamei, Fuminori Tatsumi, et al.. (2021). Multiple endocrine neoplasia type 1 with a frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas: case report. BMC Endocrine Disorders. 21(1). 164–164.
4.
Nakanishi, Shuhei, Masashi Shimoda, Fuminori Tatsumi, et al.. (2021). Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study. Diabetes Therapy. 12(7). 1849–1860.
5.
Tatsumi, Fuminori, Yoshiro Fushimi, Junpei Sanada, et al.. (2021). Idiopathic Bilateral Extraocular Myositis in a Subject With Poorly Controlled Type 2 Diabetes Mellitus: Case Report. Frontiers in Medicine. 8. 700307–700307.
6.
Nakanishi, Shuhei, Hidenori Hirukawa, Masashi Shimoda, et al.. (2020). <p>Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1669–1676.
7.
Nakanishi, Shuhei, Hidenori Hirukawa, Masashi Shimoda, et al.. (2019). Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study. Lipids in Health and Disease. 18(1). 36–36.
8.
Obata, Atsushi, Tomohiko Kimura, Masashi Shimoda, et al.. (2019). Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice. Diabetologia. 62(7). 1225–1236.
9.
Nakanishi, Shuhei, Hidenori Hirukawa, Masashi Shimoda, et al.. (2019). Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 155. 107807–107807.
10.
Kinoshita, Tomoe, Masashi Shimoda, Junpei Sanada, et al.. (2018). There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study. Diabetes Therapy. 9(4). 1569–1580.
11.
Kimura, Tomohiko, Atsushi Obata, Masashi Shimoda, et al.. (2018). Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure. Diabetes & Metabolism. 44(3). 250–260.
12.
Kinoshita, Tomoe, Masashi Shimoda, Junpei Sanada, et al.. (2016). Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 30(8). 1452–1455.
13.
Obata, Atsushi, Shinji Kamei, Seizo Okauchi, et al.. (2016). Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy. SpringerPlus. 5(1). 1499–1499.
14.
Muroi, Carl, Atsushi Obata, Edin Nevzati, et al.. (2016). Evaluation of a filament perforation model for mouse subarachnoid hemorrhage using 7.0 Tesla MRI. Journal of Clinical Neuroscience. 28. 141–147.
15.
Hirukawa, Hidenori, Hideaki Kaneto, Masashi Shimoda, et al.. (2015). Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expression. Molecular and Cellular Endocrinology. 413. 49–60.
16.
Yoshimoto, Mitsuyoshi, Atsuo Waki, Atsushi Obata, et al.. (2004). Radiolabeled choline as a proliferation marker: Comparison with radiolabeled acetate. Nuclear Medicine and Biology. 31(7). 859–865.
17.
Obata, Atsushi, Mitsuyoshi Yoshimoto, Shingo Kasamatsu, et al.. (2003). Intra-tumoral distribution of 64Cu-ATSM: a comparison study with FDG. Nuclear Medicine and Biology. 30(5). 529–534.
18.
Masuyama, Keisuke, et al.. (2002). Localized Wegener's granulomatosis complaining of mixed hearing loss: A case report. 12(5). 595–599.
19.
Obata, Atsushi, Atsuo Waki, Jason S. Lewis, et al.. (2001). Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Annals of Nuclear Medicine. 15(6). 499–504.
20.
Yoshimura, Shinichi, Nobuo Hashimoto, Kiyoshi Kazekawa, et al.. (1995). Arteriovenous fistula around the ventriculoperitoneal shunt system in a patient with a dural arteriovenous malformation of the posterior fossa. Journal of neurosurgery. 82(2). 288–290.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by In Joo Kim Breakdown of academic impact, for papers by Joanna Kłubo-Gwieździńska Breakdown of academic impact, for papers by Gabriela M. Kuster Breakdown of academic impact, for papers by Tomonori Itoh Breakdown of academic impact, for papers by Henrik Wiggers Breakdown of academic impact, for papers by Keisuke Ohba Breakdown of academic impact, for papers by Nadia Haddy Breakdown of academic impact, for papers by John J. Ryan Breakdown of academic impact, for papers by Charles Intenzo Breakdown of academic impact, for papers by Sunghwan Suh